Gilyazova, I.R.,
Ivanova, E.A.,
Bermisheva, M.A.,
Loginova, M.V.,
Asadullina, D.D.,
Ishemgulov, R.R.,
Mustafin, A.T.,
Pavlov, V.N.,
Khusnutdinova, E.K. (2022) of PTEN, rs17878362 of TP53, and rs2699887 of PIK3CA with the risk of prostate cancer development. As
aYing Xu,
Dennis Nguyen,
Armin Mohamed,
Cheryl Carcel,
Qiang Li,
Kutlubaev, M.A.,
Anderson, Craig S.,
Hackett, Maree L. (2016) and consequences.
Method:
A systematic review of all published observational studies (to November 2015
Afolabi, A.,
Hu, SN.,
Wang, C.,
Zhu, YC.,
Mustafina, I.,
Lin, L.,
Zheng, GH.,
Zhe, CY.,
Jia, HB.,
Hou, JB.,
Yu, B. (2017) burden in high-income countries. ACS refers to
a constellation of clinical symptoms that are compatible
AKHMADIEV, N.S.,
AKHMETOVA, V.R.,
IBRAGIMOV, A.G.,
GALIMOVA, A.M.,
GALIMOVA, R.A.,
AGLETDINOV, E.F.,
KATAEV, V.A.,
KHAIRULLINA, V.R. (2019) to the active sites of an enzymatic oxidase system. To obtain
a deeper insight into biochemical aspects
Han, Z.B.,
Wang, X.X.,
Xu, Z.H.,
Cao, Y.,
Gong, R,
Zagidullin, N.,
Sukhareva, N.,
Zhang, Y. (2021) N-6-methyladenosine (m(6)
A) RNA modification,
a dynamic and reversible process, is essential